Credit Suisse to Advise Hanwha on Possible Dow Chlor-alkali Buy

No potential buyers have yet come forward announcing plans to buy the chlor-alkali business Dow Chemical has said it plans to sell. However, South Korea's Hanwha Chemical said it has engaged Credit Suisse to advise it on possible purchases.

A spokesman for Hanwha told the news agency Reuters its interest is "in the early stages."

As part of plans to "right size" its chlorine footprint to meet its needs in downstream markets, Dow in December 2013 said it would carve out "a significant portion" of its chlorine value chain over the next two years.

The U.S. group said it expected to dispose of assets with $5 billion in annual revenue, including more than 40 production units at 11 sites employing nearly 2,000 people.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.